Market Tracker

09/22 5:16pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.11
Delayed Data
As of Sep 22
 +0.01 / +0.24%
Today’s Change
3.15
Today|||52-Week Range
9.19
-0.48%
Year-to-Date

Today’s Trading

Previous close4.10
Today’s open4.08
Day’s range4.00 - 4.16
Volume794,057
Average volume (3 months)1,897,413
Market cap$562.1M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-1,025.00%
Earnings growth (this year)-54.22%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-77.31%
P/E ratioNM
Price/Sales37.63
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.17+1.01%
VSARVersartis Inc-18.93-87.62%
SGYPSynergy Pharmaceutic...-0.05-1.89%
INSYINSYS Therapeutics I...-0.06-0.68%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$15.0M
Annual profit (last year)-$61.7M
Net profit margin-411.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
Chief Operating Officer &
Executive Vice President
Joseph Truitt
Corporate headquarters
New Haven, Connecticut

Forecasts